Refreshing results…
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
Download from doi.orgEfficacy and immune-related adverse event associations in avelumab-treated patients
Download from doi.orgMissing publications? Search for publications with a matching author name.